美国上市药品（最近批准）
按批准日期最近更新
| 药品名称 | 商品名 | 申请号 | 产品编号 | 剂型 | 规格 | 企业 | 市场状态 | 批准日期 | 上市日期 |
|---|---|---|---|---|---|---|---|---|---|
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | ANDA215701 | 001 | INJECTABLE;INJECTION | 200MG/2ML(100MG/ML) | SHANDONG | None (Tentative Approval) | 2026-10-06 | 2026-10-06 |
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | ANDA215701 | 002 | INJECTABLE;INJECTION | 500MG/5ML(100MG/ML) | SHANDONG | None (Tentative Approval) | 2026-10-06 | 2026-10-06 |
| SOLRIAMFETOL HYDROCHLORIDE | SOLRIAMFETOL HYDROCHLORIDE | ANDA218725 | 001 | TABLET | 150MG | AUROBINDO PHARMA LTD | None (Tentative Approval) | 2026-10-06 | 2026-10-06 |
| SOLRIAMFETOL HYDROCHLORIDE | SOLRIAMFETOL HYDROCHLORIDE | ANDA218725 | 002 | TABLET;ORAL | EQ 75MG BASE | AUROBINDO PHARMA LTD | Prescription | 2026-10-06 | 2026-10-06 |
| SOLRIAMFETOL HYDROCHLORIDE | SOLRIAMFETOL HYDROCHLORIDE | ANDA218725 | 003 | TABLET;ORAL | EQ 150MG BASE | AUROBINDO PHARMA LTD | Prescription | 2026-10-06 | 2026-10-06 |
| DESFLURANE | DESFLURANE | ANDA090363 | 001 | LIQUID;INHALATION | 100% | PIRAMAL CRITICAL | Prescription | 2026-10-05 | 2026-10-05 |
| PERAMPANEL | PERAMPANEL | ANDA220492 | 001 | TABLET;ORAL | 2MG | AUROBINDO PHARMA LTD | Prescription | 2026-10-02 | 2026-10-02 |
| PERAMPANEL | PERAMPANEL | ANDA220492 | 002 | TABLET;ORAL | 4MG | AUROBINDO PHARMA LTD | Prescription | 2026-10-02 | 2026-10-02 |
| PERAMPANEL | PERAMPANEL | ANDA220492 | 003 | TABLET;ORAL | 6MG | AUROBINDO PHARMA LTD | Prescription | 2026-10-02 | 2026-10-02 |
| PERAMPANEL | PERAMPANEL | ANDA220492 | 004 | TABLET;ORAL | 8MG | AUROBINDO PHARMA LTD | Prescription | 2026-10-02 | 2026-10-02 |